The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading neutral. Over the past year the shares are up 14900%. Our forward projection puts the odds of a 10% gain over the next month near 0%.
Vaxxinity, Inc. VAXX
Outside both standardsAn entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
read at $0.00
Vaxxinity, Inc. holds its Accumulation at $0.00.
- PHPhase · the trend structure carries the Accumulation label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 2 days |
| Price | $0.00 |
| Valuation | 0.00 trailing · 0.00 forward price to earnings |
| Values screen | FAIL |
| Beta | N/A |
The business, in plain words · what the numbers mean
| Forward P/E | 0.0x |
| Trailing P/E | 0.0x |
| Revenue growth | 0.0% revenue is shrinking |
| Profit margin | 0.0% currently unprofitable |
| Return on equity | -150.6% not currently earning a positive return on equity |
| Debt to equity | 1.13 a meaningful debt load worth watching |
| Market cap | $12,678 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & how to trade · wherever in the world you are
VAXX trades on PNK. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $0.00 | +14,900.0% | · | $150,000 | +14,900.0% |
| 2 months | $0.00 | +14,900.0% | · | $150,000 | +14,900.0% |
| 3 months | $0.01 | +50.0% | · | $1,500 | +50.0% |
| 6 months | $0.00 | +4,900.0% | · | $50,000 | +4,900.0% |
| 1 year | $0.00 | +14,900.0% | · | $150,000 | +14,900.0% |
| 2 years | $0.09 | -84.2% | · | $158 | -84.2% |
| 3 years | $1.88 | -99.2% | · | $8 | -99.2% |
Historical returns from market close data. Past performance does not guarantee future results.